Literature DB >> 34245862

TMEM97 ablation aggravates oxidant-induced retinal degeneration.

Hongtao Shen1, Jing Li1, Tyler Heisler-Taylor2, Ryan Makin3, Huan Yang4, Timur A Mavlyutov4, Bradley Gelfand5, Colleen M Cebulla6, Lian-Wang Guo7.   

Abstract

The retinal pigment epithelium (RPE) is critical to the survival of the overlying photoreceptors. Subject to light exposure and active metabolism, the RPE and photoreceptors are particularly susceptible to oxidative damage that plays an important part in age-related macular degeneration (AMD). Recent meta-analyses identified TMEM97 as a new putative AMD risk locus, though it is yet to be functionally verified. The role of TMEM97 in the retina and RPE is not known. Here we investigated TMEM97 function using the sodium iodate model of oxidant-induced retinal degeneration in TMEM97 knockout (KO) mice. We found markedly increased reactive oxygen species (ROS) and loss of photoreceptos in TMEM97 KO mouse retinas relative to wild type (WT) controls. In vitro, sodium iodate treatment of CRISPR-mediated TMEM97 KO RPE cells resulted in diminished abundance of the master antioxidant transcription factor NRF2 and its target gene product SOD2, the mitochondrial superoxide dismutase, as well as elevated ROS and apoptosis markers. Moreover, TMEM97 KO affected proteins key to mitochondrial and lysosomal stability and impeded autophagy flux. These findings suggest that the absence of TMEM97 in RPE cells disturbs redox-balancing systems, thereby heightening oxidative stress. As TMEM97 is a druggable target, this study may inspire interest in basic and translational research in the context of retinal degeneration.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Keywords:  Lysosome; Mitochondria; Oxidative stress; Photoreceptor; RPE; Retina; TMEM97

Mesh:

Substances:

Year:  2021        PMID: 34245862      PMCID: PMC8869839          DOI: 10.1016/j.cellsig.2021.110078

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  51 in total

Review 1.  The impact of oxidative stress and inflammation on RPE degeneration in non-neovascular AMD.

Authors:  Sayantan Datta; Marisol Cano; Katayoon Ebrahimi; Lei Wang; James T Handa
Journal:  Prog Retin Eye Res       Date:  2017-03-20       Impact factor: 21.198

Review 2.  Lysosomal membrane permeabilization and cell death.

Authors:  Fengjuan Wang; Raquel Gómez-Sintes; Patricia Boya
Journal:  Traffic       Date:  2018-09-12       Impact factor: 6.215

3.  The Project MACULA Retinal Pigment Epithelium Grading System for Histology and Optical Coherence Tomography in Age-Related Macular Degeneration.

Authors:  Emma C Zanzottera; Jeffrey D Messinger; Thomas Ach; R Theodore Smith; K Bailey Freund; Christine A Curcio
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-05       Impact factor: 4.799

4.  Sigma 1 receptor regulates the oxidative stress response in primary retinal Müller glial cells via NRF2 signaling and system xc(-), the Na(+)-independent glutamate-cystine exchanger.

Authors:  Jing Wang; Arul Shanmugam; Shanu Markand; Eric Zorrilla; Vadivel Ganapathy; Sylvia B Smith
Journal:  Free Radic Biol Med       Date:  2015-04-25       Impact factor: 7.376

5.  Dysregulated autophagy in the RPE is associated with increased susceptibility to oxidative stress and AMD.

Authors:  Sayak K Mitter; Chunjuan Song; Xiaoping Qi; Haoyu Mao; Haripriya Rao; Debra Akin; Alfred Lewin; Maria Grant; William Dunn; Jindong Ding; Catherine Bowes Rickman; Michael Boulton
Journal:  Autophagy       Date:  2014       Impact factor: 16.016

6.  A super-ecliptic, pHluorin-mKate2, tandem fluorescent protein-tagged human LC3 for the monitoring of mammalian autophagy.

Authors:  Isei Tanida; Takashi Ueno; Yasuo Uchiyama
Journal:  PLoS One       Date:  2014-10-23       Impact factor: 3.240

7.  The vacuolar-ATPase complex and assembly factors, TMEM199 and CCDC115, control HIF1α prolyl hydroxylation by regulating cellular iron levels.

Authors:  Anna L Miles; Stephen P Burr; Guinevere L Grice; James A Nathan
Journal:  Elife       Date:  2017-03-15       Impact factor: 8.140

8.  A phase 1 clinical trial of the sigma-2 receptor complex allosteric antagonist CT1812, a novel therapeutic candidate for Alzheimer's disease.

Authors:  Michael Grundman; Roger Morgan; Jason D Lickliter; Lon S Schneider; Steven DeKosky; Nicholas J Izzo; Robert Guttendorf; Michelle Higgin; Julie Pribyl; Kelsie Mozzoni; Hank Safferstein; Susan M Catalano
Journal:  Alzheimers Dement (N Y)       Date:  2019-01-23

Review 9.  A systems biology approach towards understanding and treating non-neovascular age-related macular degeneration.

Authors:  James T Handa; Cathy Bowes Rickman; Andrew D Dick; Michael B Gorin; Joan W Miller; Cynthia A Toth; Marius Ueffing; Marco Zarbin; Lindsay A Farrer
Journal:  Nat Commun       Date:  2019-07-26       Impact factor: 14.919

10.  The Sigma 2 receptor promotes and the Sigma 1 receptor inhibits mu-opioid receptor-mediated antinociception.

Authors:  Pilar Sánchez-Blázquez; Elsa Cortés-Montero; María Rodríguez-Muñoz; Manuel Merlos; Javier Garzón-Niño
Journal:  Mol Brain       Date:  2020-11-11       Impact factor: 4.041

View more
  2 in total

1.  Identification of Human Retinal Organoid Cell Differentiation-Related Genes via Single-Cell Sequencing Data Analysis.

Authors:  He Dong; Liang Yu; Jian Song; Lili Ji; Xiaoxia Yu; Lijun Zhang
Journal:  Comput Math Methods Med       Date:  2022-08-08       Impact factor: 2.809

2.  Differential Responses to Sigma-1 or Sigma-2 Receptor Ablation in Adiposity, Fat Oxidation, and Sexual Dimorphism.

Authors:  Jing Li; Elisa Félix-Soriano; Katherine R Wright; Hongtao Shen; Lisa A Baer; Kristin I Stanford; Lian-Wang Guo
Journal:  Int J Mol Sci       Date:  2022-09-16       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.